1
IRUS Total
Downloads

Interstitial lung disease incidence and mortality in the United Kingdom and the European Union: an observational study, 2001-2017

File Description SizeFormat 
00058-2022.full.pdfPublished version626.49 kBAdobe PDFView/Open
Title: Interstitial lung disease incidence and mortality in the United Kingdom and the European Union: an observational study, 2001-2017
Authors: Salciccioli, J
Marshall, D
Goodall, R
Crowley, C
Shalhoub, J
Patel, P
Molyneaux, P
Item Type: Journal Article
Abstract: Objective: To compare the trends in age-standardised incidence and mortality from interstitial lung diseases (ILD) in the United Kingdom (UK) and the European Union (EU). Design: Observational study using data obtained from the Global Burden of Disease Study. Setting and Participants: Residents of the UK and of the twenty-seven EU countries. Main outcome measures: ILD age-standardised incidence rates per 100 000 (ASIR), age-standardised death rates per 100 000 (ASDR), and mortality-to-incidence ratio (MIRs) are presented for males and females separately for each country, for the years 2001–2017. Trends were analysed using Joinpoint regression analysis. Results: For men, in 2017, the median incidence of ILD was 7.22 (IQR 5.57–8.96) per 100 000 population. For women, in 2017, the median incidence of ILD was 4.34 (IQR 3.36–6.29) per 100 000 population. For men, in 2017, the median ASDR attributed to ILD was 2.04 (IQR 1.13–2.71) per 100 000 population. For women, the median ASDR in 2017 for ILD was 1.02 (0.68–1.37) per 100 000 population. There was an overall increase in ASDR during the observation period with a median change of +20.42% (IQR 5.44–31.40) for men and an increase of +15.44% (IQR −1.01–31.52) for women. Despite increases in mortality over the entire observation period, there were decreasing mortality trends in the majority of countries at the end of the observation period (75% for men and 86% for women). Conclusion: Over the past two decades, there have been increases in the incidence and mortality of interstitial lung diseases in Europe. The most recent trends, however, demonstrate decreases in mortality from ILD in the majority of European countries for both men and women. These data support the ongoing improvements in the diagnosis and management of ILD.
Issue Date: 11-Jul-2022
Date of Acceptance: 6-Apr-2022
URI: http://hdl.handle.net/10044/1/96887
DOI: 10.1183/23120541.00058-2022
ISSN: 2312-0541
Publisher: European Respiratory Society
Start Page: 1
End Page: 12
Journal / Book Title: ERJ Open Research
Volume: 8
Issue: 3
Copyright Statement: © The authors 2022. This version is distributed under the terms of the Creative Commons Attribution Licence 4.0.
Sponsor/Funder: Action for Pulmonary Fibrosis
Funder's Grant Number: n/a
Publication Status: Published
Online Publication Date: 2022-07-11
Appears in Collections:Department of Surgery and Cancer
National Heart and Lung Institute
Faculty of Medicine



This item is licensed under a Creative Commons License Creative Commons